Vis enkel innførsel

dc.contributor.authorSolberg, Runar Barstad
dc.contributor.authorFretheim, Atle
dc.contributor.authorElgersma, Ingeborg Hess
dc.contributor.authorFagernes, Mette
dc.contributor.authorIversen, Bjørn Gunnar
dc.contributor.authorHemkens, Lars G.
dc.contributor.authorRose, Christopher James
dc.contributor.authorElstrøm, Petter
dc.date.accessioned2024-10-30T08:47:29Z
dc.date.available2024-10-30T08:47:29Z
dc.date.created2024-08-05T15:58:41Z
dc.date.issued2024
dc.identifier.citationThe BMJ. 2024, 386 .en_US
dc.identifier.issn1756-1833
dc.identifier.urihttps://hdl.handle.net/11250/3161497
dc.description.abstractObjective: To evaluate the personal protective effects of wearing versus not wearing surgical face masks in public spaces on self-reported respiratory symptoms over a 14 day period. Design: Pragmatic randomised superiority trial. Setting: Norway. Participants: 4647 adults aged ≥18 years: 2371 were assigned to the intervention arm and 2276 to the control arm. Interventions: Participants in the intervention arm were assigned to wear a surgical face mask in public spaces (eg, shopping centres, streets, public transport) over a 14 day period (mask wearing at home or work was not mentioned). Participants in the control arm were assigned to not wear a surgical face mask in public places. Main outcome measures: The primary outcome was self-reported respiratory symptoms consistent with a respiratory infection. Secondary outcomes included self-reported and registered covid-19 infection and self-reported sick leave. Results: Between 10 February 2023 and 27 April 2023, 4647 participants were randomised of whom 4575 (2788 women (60.9%); mean age 51.0 (standard deviation 15.0) years) were included in the intention-to-treat analysis: 2313 (50.6%) in the intervention arm and 2262 (49.4%) in the control arm. 163 events (8.9%) of self-reported symptoms consistent with respiratory infection were reported in the intervention arm and 239 (12.2%) in the control arm. The marginal odds ratio was 0.71 (95% confidence interval (CI) 0.58 to 0.87; P=0.001) favouring the face mask intervention. The absolute risk difference was −3.2% (95% CI −5.2% to −1.3%; P<0.001). No statistically significant effect was found on self- reported (marginal odds ratio 1.07, 95% CI 0.58 to 1.98; P=0.82) or registered covid-19 infection (effect estimate and 95% CI not estimable owing to lack of events in the intervention arm). Self-reported sick leave was equally distributed between the intervention and control groups (marginal odds ratio 1.00, 0.81 to 1.22; P=0.97). Conclusion: Wearing a surgical face mask in public spaces over 14 days reduces the risk of self-reported symptoms consistent with a respiratory infection, compared with not wearing a surgical face mask.en_US
dc.language.isoengen_US
dc.publisherBMJ Publishing Groupen_US
dc.relation.ispartofseriesThe BMJ;
dc.rightsNavngivelse-Ikkekommersiell 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/deed.no*
dc.titlePersonal protective effect of wearing surgical face masks in public spaces on self-reported respiratory symptoms in adults: pragmatic randomised superiority trialen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2
dc.identifier.doihttp://dx.doi.org/10.1136/bmj-2023-078918
dc.identifier.cristin2284515
dc.source.journalThe BMJen_US
dc.source.volume386en_US
dc.source.pagenumber9en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse-Ikkekommersiell 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse-Ikkekommersiell 4.0 Internasjonal